Skip to main content
Top
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004

Authors: Nadia Valin, Gilles Hejblum, Isabelle Borget, Henri-Pierre Mallet, Fadi Antoun, Didier Che, Christos Chouaid

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

Few data are available on prescriber adherence to tuberculosis (TB) treatment guidelines. In particular, excessively long treatment carries a risk of avoidable adverse effects and represents a waste of healthcare resources. We examined factors potentially associated with excessively long treatment.

Methods

We reviewed the medical records of patients diagnosed with TB in 2004 in the eastern Paris region. Sociodemographic and clinical factors associated with excessively long treatment were identified by logistic regression analyses. Based on contemporary guidelines, excessively long treatment was defined as more than 6 months of a four-drug regimen for thoracic TB with full sensitive strains, and more than 12 months for patients with extrathoracic TB.

Results

Analyses concerned 478 patients with a median age of 36.0 ± 13.5 years, of whom 48% were living in precarious conditions (i.e. poor living conditions and/or no health insurance), 80% were born abroad, and 17% were HIV-seropositive. TB was restricted to the chest in 279 patients (isolated pulmonary, pleuropulmonary, and isolated pleural TB in 245, 13, and 21 patients, respectively), exclusively extrathoracic in 115 patients, and mixed in the remaining 84 patients. Treatment was prescribed by a chest specialist in 211 cases (44.1%) and 295 patients (61.7%) were managed in a single institution. The treatment duration complied with contemporary guidelines in 316 cases (66.1%) and was excessively long in 162 cases (33.9%). The median duration of excessively long treatment was 313 days (IQR: 272-412). In multivariate analysis, isolated thoracic TB, previous TB, HIV infection, a prescriber other than a chest specialist, and management in more than one healthcare center during treatment were independently associated with excessively lengthy treatment.

Conclusion

One-third of TB patients received excessively long treatment, reflecting inadequate awareness of management guidelines or unwillingness to implement them.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don't physicians follow clinical practice guidelines? A framework for improvement. Jama. 1999, 282: 1458-65. 10.1001/jama.282.15.1458.CrossRefPubMed Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don't physicians follow clinical practice guidelines? A framework for improvement. Jama. 1999, 282: 1458-65. 10.1001/jama.282.15.1458.CrossRefPubMed
2.
go back to reference Sumartojo EM, Geiter LJ, Miller B, Hale BE: Can physicians treat tuberculosis? Report on a national survey of physician practices. Am J Public Health. 1997, 87: 2008-11. 10.2105/AJPH.87.12.2008.CrossRefPubMedPubMedCentral Sumartojo EM, Geiter LJ, Miller B, Hale BE: Can physicians treat tuberculosis? Report on a national survey of physician practices. Am J Public Health. 1997, 87: 2008-11. 10.2105/AJPH.87.12.2008.CrossRefPubMedPubMedCentral
3.
go back to reference Tattevin P, Chapplain JM, Lesprit P, Billy C, Roblot F, Alfandari S, Bernard L, Rouveix E, Bouvet E: Tuberculosis treatment duration in France: From guidelines to daily practice. Eur J Intern Med. 2006, 17: 427-9. 10.1016/j.ejim.2006.02.021.CrossRefPubMed Tattevin P, Chapplain JM, Lesprit P, Billy C, Roblot F, Alfandari S, Bernard L, Rouveix E, Bouvet E: Tuberculosis treatment duration in France: From guidelines to daily practice. Eur J Intern Med. 2006, 17: 427-9. 10.1016/j.ejim.2006.02.021.CrossRefPubMed
4.
go back to reference Valin N, Hejblum G, Borget I, Mallet HP, Antoun F, Che D, Chouaid C: Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004. Int J Tuberc Lung Dis. 2009, 13: 881-7.PubMed Valin N, Hejblum G, Borget I, Mallet HP, Antoun F, Che D, Chouaid C: Management and treatment outcomes of tuberculous patients, eastern Paris, France, 2004. Int J Tuberc Lung Dis. 2009, 13: 881-7.PubMed
6.
go back to reference Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003, 167: 603-62. 10.1164/rccm.167.4.603.CrossRefPubMed Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, et al: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003, 167: 603-62. 10.1164/rccm.167.4.603.CrossRefPubMed
7.
go back to reference Tattevin P: Tuberculosis treatment in 2007. Med Mal Infect. 2007, 37: 617-28. 10.1016/j.medmal.2007.02.009.CrossRefPubMed Tattevin P: Tuberculosis treatment in 2007. Med Mal Infect. 2007, 37: 617-28. 10.1016/j.medmal.2007.02.009.CrossRefPubMed
8.
go back to reference Prasad R, Nautiyal RG, Mukherji PK, Jain A, Singh K, Ahuja RC: Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India?. Int J Tuberc Lung Dis. 2002, 6: 895-902.PubMed Prasad R, Nautiyal RG, Mukherji PK, Jain A, Singh K, Ahuja RC: Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India?. Int J Tuberc Lung Dis. 2002, 6: 895-902.PubMed
9.
go back to reference Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, et al: An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006, 174: 935-52. 10.1164/rccm.200510-1666ST.CrossRefPubMed Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, et al: An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006, 174: 935-52. 10.1164/rccm.200510-1666ST.CrossRefPubMed
10.
go back to reference Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J: Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007, 4: e238-10.1371/journal.pmed.0040238.CrossRefPubMedPubMedCentral Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J: Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007, 4: e238-10.1371/journal.pmed.0040238.CrossRefPubMedPubMedCentral
11.
go back to reference Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, et al: Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. Aids. 2002, 16: 75-83. 10.1097/00002030-200201040-00010.CrossRefPubMed Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, et al: Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. Aids. 2002, 16: 75-83. 10.1097/00002030-200201040-00010.CrossRefPubMed
12.
go back to reference Hull MW, Phillips P, Montaner JS: Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest. 2008, 134: 1287-98. 10.1378/chest.08-0364.CrossRefPubMed Hull MW, Phillips P, Montaner JS: Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest. 2008, 134: 1287-98. 10.1378/chest.08-0364.CrossRefPubMed
13.
go back to reference Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL: Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med. 2007, 175: 1199-206. 10.1164/rccm.200509-1529OC.CrossRefPubMedPubMedCentral Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL: Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med. 2007, 175: 1199-206. 10.1164/rccm.200509-1529OC.CrossRefPubMedPubMedCentral
15.
go back to reference Mitchell E, Sullivan F: A descriptive feast but an evaluative famine: systematic review of published articles on primary care computing during 1980-97. Bmj. 2001, 322: 279-82. 10.1136/bmj.322.7281.279.CrossRefPubMedPubMedCentral Mitchell E, Sullivan F: A descriptive feast but an evaluative famine: systematic review of published articles on primary care computing during 1980-97. Bmj. 2001, 322: 279-82. 10.1136/bmj.322.7281.279.CrossRefPubMedPubMedCentral
16.
go back to reference Bourgarit A, Mallet HP, Keshtmand H, De Castro N, Rambeloarisoa J, Fain O, Antoun F, Picard C, Rocher G, Che D, et al: Follow-up of 208 tuberculosis patients treated in 2004 with the assistance of TB-info software. Rev Med Interne. 2009, 30: 841-6. 10.1016/j.revmed.2009.03.362.CrossRefPubMed Bourgarit A, Mallet HP, Keshtmand H, De Castro N, Rambeloarisoa J, Fain O, Antoun F, Picard C, Rocher G, Che D, et al: Follow-up of 208 tuberculosis patients treated in 2004 with the assistance of TB-info software. Rev Med Interne. 2009, 30: 841-6. 10.1016/j.revmed.2009.03.362.CrossRefPubMed
17.
go back to reference Farge D, Porcher R, Antoun F, Fain O, Keshtmand H, Rocher G, Mallet HP, Rambeloarisoa J, Gerber F, De Castro N, et al: Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France. Int J Tuberc Lung Dis. 2007, 11: 992-8.PubMed Farge D, Porcher R, Antoun F, Fain O, Keshtmand H, Rocher G, Mallet HP, Rambeloarisoa J, Gerber F, De Castro N, et al: Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France. Int J Tuberc Lung Dis. 2007, 11: 992-8.PubMed
18.
go back to reference Antoine D, French GE, Jones J, Watson JM: Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001. J Epidemiol Community Health. 2007, 61: 302-7. 10.1136/jech.2005.044404.CrossRefPubMedPubMedCentral Antoine D, French GE, Jones J, Watson JM: Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001. J Epidemiol Community Health. 2007, 61: 302-7. 10.1136/jech.2005.044404.CrossRefPubMedPubMedCentral
19.
go back to reference Diel R, Niemann S: Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. Int J Tuberc Lung Dis. 2003, 7: 124-31.PubMed Diel R, Niemann S: Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. Int J Tuberc Lung Dis. 2003, 7: 124-31.PubMed
20.
go back to reference Vasankari T, Holmstrom P, Ollgren J, Liippo K, Kokki M, Ruutu P: Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health. 2007, 7: 291-10.1186/1471-2458-7-291.CrossRefPubMedPubMedCentral Vasankari T, Holmstrom P, Ollgren J, Liippo K, Kokki M, Ruutu P: Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health. 2007, 7: 291-10.1186/1471-2458-7-291.CrossRefPubMedPubMedCentral
21.
go back to reference LoBue PA, Moser K, Catanzaro A: Management of tuberculosis in San Diego County: a survey of physicians' knowledge, attitudes and practices. Int J Tuberc Lung Dis. 2001, 5: 933-8.PubMed LoBue PA, Moser K, Catanzaro A: Management of tuberculosis in San Diego County: a survey of physicians' knowledge, attitudes and practices. Int J Tuberc Lung Dis. 2001, 5: 933-8.PubMed
22.
go back to reference Comité national d'élaboration du programme de lutte contre la tuberculose: Programme de lutte contre la tuberculose en France 2007-2009. 2007 Comité national d'élaboration du programme de lutte contre la tuberculose: Programme de lutte contre la tuberculose en France 2007-2009. 2007
Metadata
Title
Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004
Authors
Nadia Valin
Gilles Hejblum
Isabelle Borget
Henri-Pierre Mallet
Fadi Antoun
Didier Che
Christos Chouaid
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-495

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue